 Home > Pharmaceutical Intermediates > Antineoplastics > N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide for Sale > N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide 885126-35-2

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide 885126-35-2 buy - large image1

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide 885126-35-2

Name: N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide 885126-35-2
Brand: Zison
SKU: pr2302081393
Price: 7150 USD
Availability: InStock

Unit Price: Get Latest Price 

CAS No.:

885126-35-2

Grade:

Pharmaceutical Grade

Content:

99%

Brand:

Zison

Packaging:

foil bag

Price valid (until):

2023-02-28

Contact Supplier

 Chat Now

Zison Pharmaceutical (Shandong)Co.,Ltd.

Company Type:

Manufactory

Location:

China

Qualification:

Main Products:

Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib

 Visit Store

Product Description
Seller Information

Description

Product Detail

Axitinib Intermediate CAS:885126-35-2
Items Specifications
Molecular formula
C27H26N4O2S

Molecular weight 470.59
Density 1.28

Basic Info

Product Name:
N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide

Other Name:
Benzamide,N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]-;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide

CAS No.:
885126-35-2

Molecular Formula:
C27H26N4O2S

InChIKeys:
InChIKey=ICISLZFPVJBDJL-NTCAYCPXNA-N

Molecular Weight:
470.6

Exact Mass:
470.59

Categories:
Antineoplastics

Characteristics
Seller Information

Business Type:
Manufactory

Main Products:
Avatrombopag,Lenvatinib,Safinamide mesylate,Axitinib

Location:
Room 410, Building 9, No. 2566, Century Avenue, Jinan, 250104, China

Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance

Average lead Time:
10

Total Annual Revenue:
$2.5 million-$5 million

Total Employees:
51-100

Year of Establishment:
2021

Certifications:
business license,ISO

Zison Pharma,a leading manufacturer of APIs and pharma intermediates(Axitinib and intermediates, Avatrombopag and intermediates,Finerenone and intermediates,Lenvatinib and intermediates,Tenofovir alafenamide hemifumarate and intermediates,Safinamide and intermediates,Crizotinib and intermediates, Roxadustat and intermediates, Calcipotriene monohydrate and intermediates etc.)based in Jinan, China. With 10 years of experience in the APIs and pharma intermediates field, we understand that quality and service is the key to win in the fast-changing market and our client's success is our success,which is why in our customer relations we always put the needs of our clients first.
Country Product Purchase Quantity Date Posted

Post an enquiry for this product

Items	Specifications
Molecular formula	C27H26N4O2S
Molecular weight	470.59
Density	1.28

N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-6-yl]thio]benzamide 885126-35-2

Product Description

Seller Information

Related Searches